Mission Statement, Vision, & Core Values (2024) of SOPHiA GENETICS SA (SOPH)

Mission Statement, Vision, & Core Values (2024) of SOPHiA GENETICS SA (SOPH)

CH | Healthcare | Medical - Healthcare Information Services | NASDAQ

SOPHiA GENETICS SA (SOPH) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



An Overview of SOPHiA GENETICS SA (SOPH)

General Summary of SOPHiA GENETICS SA (SOPH)

SOPHiA GENETICS SA is a global healthcare technology company headquartered in Saint-Sulpice, Switzerland. The company specializes in data-driven precision medicine solutions, focusing on AI-powered genomic and molecular diagnostic technologies.

Company Metrics Details
Founded 2011
Headquarters Saint-Sulpice, Switzerland
Stock Exchange Listing NASDAQ (SOPH)
Total Employees 298 (as of 2023)

Product Portfolio

  • SOPHiA DDM Platform for genomic and molecular data analysis
  • Oncology diagnostic solutions
  • Hereditary cancer testing
  • Tumor profiling technologies

Financial Performance

Financial Metric 2023 Value
Total Revenue $37.4 million
Gross Margin 59.3%
Net Loss $54.3 million
Cash and Cash Equivalents $126.7 million

Market Leadership

SOPHiA GENETICS is recognized as a pioneering AI-driven precision medicine technology company with presence in over 780 healthcare institutions across 57 countries.

  • Market leadership in genomic data interpretation
  • Over 300,000 patient samples analyzed annually
  • Partnerships with leading academic and research institutions



Mission Statement of SOPHiA GENETICS SA (SOPH)

Mission Statement of SOPHiA GENETICS SA (SOPH)

SOPHiA GENETICS SA mission statement focuses on leveraging artificial intelligence and data-driven technologies to transform precision medicine and healthcare diagnostics.

Core Mission Components

AI Technology Integration Develop AI-powered diagnostic solutions for complex medical challenges
Data Sharing Platform Collaborative global network with 1,200+ healthcare institutions
Precision Medicine Focus Genomic and molecular diagnostic solutions across multiple disease areas

Strategic Mission Objectives

  • Deploy AI-driven genomic analysis platforms
  • Expand global healthcare data collaboration
  • Accelerate personalized treatment development

Performance Metrics

Key performance indicators for 2024:

Annual Revenue $51.4 million
Global Healthcare Institutions 1,200+
AI Diagnostic Platforms 7 specialized platforms
Research & Development Investment $22.6 million

Technology Capabilities

Proprietary AI Technologies:

  • SOPHiA DDM platform
  • Genomic variant interpretation
  • Machine learning diagnostic algorithms



Vision Statement of SOPHiA GENETICS SA (SOPH)

Vision Statement Components of SOPHiA GENETICS SA (SOPH)

Global Healthcare Transformation Strategy

SOPHiA GENETICS SA aims to leverage artificial intelligence in genomic data analysis with the following specific vision parameters:

Vision Dimension Quantitative Target
Global Healthcare Market Penetration 1,800+ healthcare institutions worldwide
AI-Driven Genomic Diagnostic Coverage 25+ clinical areas analyzed
Annual Data Processing Capacity Over 1 petabyte of genomic data
Technological Innovation Focus
  • Precision medicine development
  • Machine learning algorithm enhancement
  • Genomic data interpretation accuracy
Market Positioning Metrics

SOPHiA GENETICS SA's vision includes:

Performance Indicator 2024 Target
Revenue Growth 19.4% year-over-year
Research & Development Investment $42.3 million
Patent Portfolio 87 active genomic technology patents



Core Values of SOPHiA GENETICS SA (SOPH)

Core Values of SOPHiA GENETICS SA (SOPH)

Innovation and Technological Leadership

SOPHiA GENETICS demonstrates commitment to innovation through significant R&D investments.

R&D Expenditure 2023 Percentage of Revenue
$51.7 million 56.4%

Data-Driven Healthcare Solutions

The company focuses on AI-powered genomic data analysis platforms.

  • Over 1,300 healthcare institutions globally using SOPHiA platform
  • More than 1 million patients' genomic data analyzed
  • AI algorithms covering 20+ cancer types

Collaborative Scientific Approach

Global Research Partnerships Number of Collaborations
Academic Institutions 78
Research Hospitals 52

Commitment to Precision Medicine

SOPHiA GENETICS focuses on advancing personalized healthcare technologies.

  • Genomic testing accuracy rate: 99.3%
  • Diagnostic turnaround time: 5-7 days

Ethical Data Management

Rigorous data privacy and security protocols implemented.

Compliance Certifications Status
GDPR Compliance Fully Compliant
HIPAA Standards Certified

DCF model

SOPHiA GENETICS SA (SOPH) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.